3.5.0.2 html 114 183 1 false 43 0 false 6 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.SageTherapeutics.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 103 - Statement - Consolidated Balance Sheets Sheet http://www.SageTherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassified Consolidated Balance Sheets Statements 2 false false R3.htm 104 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.SageTherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 105 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.SageTherapeutics.com/taxonomy/role/StatementOfIncome Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 106 - Statement - Consolidated Statements of Cash Flows Sheet http://www.SageTherapeutics.com/taxonomy/role/StatementOfCashFlowsIndirect Consolidated Statements of Cash Flows Statements 5 false false R6.htm 107 - Disclosure - Nature of Operations Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations Nature of Operations Notes 6 false false R7.htm 108 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Summary of Significant Accounting Policies Notes 7 false false R8.htm 109 - Disclosure - Fair Value Measurements Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsFairValueMeasurementInputsDisclosureTextBlock Fair Value Measurements Notes 8 false false R9.htm 110 - Disclosure - Accrued Expenses Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsAccruedExpensesTextBlock Accrued Expenses Notes 9 false false R10.htm 111 - Disclosure - Commitments and contingencies Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and contingencies Notes 10 false false R11.htm 112 - Disclosure - Sale of Equity Securities Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsSaleOfEquitySecuritiesTextBlock Sale of Equity Securities Notes 11 false false R12.htm 113 - Disclosure - Stock-Based Compensation Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-Based Compensation Notes 12 false false R13.htm 114 - Disclosure - Net Loss Per Share Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Net Loss Per Share Notes 13 false false R14.htm 115 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 14 false false R15.htm 116 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsFairValueMeasurementInputsDisclosureTextBlockTables Fair Value Measurements (Tables) Tables http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsFairValueMeasurementInputsDisclosureTextBlock 15 false false R16.htm 117 - Disclosure - Accrued Expenses (Tables) Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsAccruedExpensesTextBlockTables Accrued Expenses (Tables) Tables http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsAccruedExpensesTextBlock 16 false false R17.htm 118 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock-Based Compensation (Tables) Tables http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock 17 false false R18.htm 119 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Net Loss Per Share (Tables) Tables http://www.SageTherapeutics.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock 18 false false R19.htm 120 - Disclosure - Nature of Operations - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation Nature of Operations - Additional Information (Detail) Details 19 false false R20.htm 121 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation Summary of Significant Accounting Policies - Additional Information (Detail) Details 20 false false R21.htm 122 - Disclosure - Fair Value Measurements - Summary of Company's Cash, Cash Equivalents and Marketable Securities (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfCompanysCashCashEquivalentsAndMarketableSecurities Fair Value Measurements - Summary of Company's Cash, Cash Equivalents and Marketable Securities (Detail) Details 21 false false R22.htm 123 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformation Fair Value Measurements - Additional Information (Detail) Details 22 false false R23.htm 124 - Disclosure - Fair Value Measurements - Summary of Marketable Securities (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfMarketableSecurities Fair Value Measurements - Summary of Marketable Securities (Detail) Details 23 false false R24.htm 125 - Disclosure - Fair Value Measurements - Summary of Marketable Securities (Parenthetical) (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfMarketableSecuritiesParenthetical Fair Value Measurements - Summary of Marketable Securities (Parenthetical) (Detail) Details 24 false false R25.htm 126 - Disclosure - Accrued Expenses - Summary of Accrued Expenses (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpenses Accrued Expenses - Summary of Accrued Expenses (Detail) Details 25 false false R26.htm 127 - Disclosure - Commitments and Contingencies - Operating Leases - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureCommitmentsAndContingenciesOperatingLeasesAdditionalInformation Commitments and Contingencies - Operating Leases - Additional Information (Detail) Details 26 false false R27.htm 128 - Disclosure - Commitments and Contingencies - CyDex License Agreement - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureCommitmentsAndContingenciesCyDexLicenseAgreementAdditionalInformation Commitments and Contingencies - CyDex License Agreement - Additional Information (Detail) Details 27 false false R28.htm 129 - Disclosure - Commitments and Contingencies - Washington University License Agreement - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureCommitmentsAndContingenciesWashingtonUniversityLicenseAgreementAdditionalInformation Commitments and Contingencies - Washington University License Agreement - Additional Information (Detail) Details 28 false false R29.htm 130 - Disclosure - Commitments and Contingencies - University of California License Agreements - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureCommitmentsAndContingenciesUniversityOfCaliforniaLicenseAgreementsAdditionalInformation Commitments and Contingencies - University of California License Agreements - Additional Information (Detail) Details 29 false false R30.htm 131 - Disclosure - Commitments and Contingencies - Consulting Agreement - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureCommitmentsAndContingenciesConsultingAgreementAdditionalInformation Commitments and Contingencies - Consulting Agreement - Additional Information (Detail) Details 30 false false R31.htm 132 - Disclosure - Sale of Equity Securities - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureSaleOfEquitySecuritiesAdditionalInformation Sale of Equity Securities - Additional Information (Detail) Details 31 false false R32.htm 133 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformation Stock-Based Compensation - Additional Information (Detail) Details 32 false false R33.htm 134 - Disclosure - Stock-Based Compensation - Summary of Recognized Stock-Based Compensation Expense (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRecognizedStockBasedCompensationExpense Stock-Based Compensation - Summary of Recognized Stock-Based Compensation Expense (Detail) Details 33 false false R34.htm 135 - Disclosure - Stock-Based Compensation - Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToComputeFairValueOfOptionGranted Stock-Based Compensation - Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted (Detail) Details 34 false false R35.htm 136 - Disclosure - Stock-Based Compensation - Summary of Activity Relating to Stock Options (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityRelatingToStockOptions Stock-Based Compensation - Summary of Activity Relating to Stock Options (Detail) Details 35 false false R36.htm 137 - Disclosure - Stock-Based Compensation - Summary of Activity Relating to Restricted Stock (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityRelatingToRestrictedStock Stock-Based Compensation - Summary of Activity Relating to Restricted Stock (Detail) Details 36 false false R37.htm 138 - Disclosure - Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShare Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Detail) Details 37 false false R38.htm 139 - Disclosure - Net Loss Per Share - Summary of Common Stock Equivalents Outstanding (Detail) Sheet http://www.SageTherapeutics.com/taxonomy/role/DisclosureNetLossPerShareSummaryOfCommonStockEquivalentsOutstanding Net Loss Per Share - Summary of Common Stock Equivalents Outstanding (Detail) Details 38 false false All Reports Book All Reports sage-20160630.xml sage-20160630.xsd sage-20160630_cal.xml sage-20160630_def.xml sage-20160630_lab.xml sage-20160630_pre.xml true true